#67 – Early Cancer Detection Testing with Dr. Whitney Jones

women in lab evaluating blood sample
#67 - Early Cancer Detection Testing with Dr. Whitney Jones

A blood test could help detect cancer earlier than previously possible

Cancer can impact every aspect of life and while there are physical screenings we have used for years to detect it, a revolutionary blood test called Galleri, has become available that may be able to detect cancer sooner than we previously had the capability to. Galleri by GRAIL is a blood test that offers cutting edge technology to help detect over 50 different types of cancer before it would otherwise be found.

Dr. Amy Brenner talks with Galleri expert, Dr. Whitney Jones in depth about this new technology and what it could mean for the health of everyone. They discuss what types of cancer Galleri looks for, who should/can do it and why. The world of cancer screening has evolved in many ways and continues to do so, as with other tests for screening cancer there are protocols to follow. Dr. Jones talks about what to do after you receive the results of the test and how often somebody should get their blood drawn for this.


We are proud to be one of the early providers for the Galleri test.



Follow us for the latest updates – 


thanks to SPECIAL GUEST:

Dr. Whitney Jones
Dr. Whitney Jones is a Gastroenterologist and cancer screening advocate. He is a former Clinical Professor of Medicine and current adjunct professor in the School of Public Health and Information Services at the University of Louisville. He is a founding member and currently serves as Chair of the Kentucky Colon Cancer Screening and Prevention Program Advisory Committee serving the uninsured and underinsured community. He is a 2020-21 alumnus of the City of Hope Intensive Course in Hereditary Cancer Risk Assessment and currently serves on the National Colorectal Cancer (CRC) Round Table’s Family History and Early Age Onset CRC Task Force. Dr. Jones joined the GRAIL Team in 2021 to advance multi-cancer early detection technology through education, policy, and clinical pathways.